Anthem Biosciences Limited
UTI Mutual Fund bought 5,32,377 shares of Anthem Biosciences for ₹39.65 Cr at ₹744.80 apiece in a block deal.
A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.
India's oldest and most storied asset manager, founded in 1963 as the Unit Trust of India under an Act of Parliament. Now manages over Rs 3.5 lakh crore with backing from four public sector institutions: LIC, SBI, Bank of Baroda, and Punjab National Bank. CIO Vetri Subramaniam is a long-term compounder with a consistent quality tilt and clear articulation of process.